Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Antikörper

Anti-FOLR1 / FRA Reference Antibody (farletuzumab)

Produktgrößen
100 ug
£385,00
CHA048-100UG
1 mg
£965,00
CHA048-1MG
Über dieses Produkt
SKU:
CHA048
Zusätzliche Namen:
farletuzumab
Anwendung:
Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
Buffer:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Klonalität:
Recombinant Monoclonal
Konzentration:
1 mg/ml
Weitere Details:
Anti-FOLR1 Reference Antibody (farletuzumab)(CHA048) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.12 kDa.
Immunogen:
FOLR1 / FRA
Isotyp:
IgG1
Physischer Zustand:
Lyophilized
Reinheit:
>95%
Reaktivitäten:
Human
Sequenz:
EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
Versandbedingungen:
Blue Ice
Spezifität:
FOLR1 / FRA
Lagerbedingungen:
2-8[o]C, -70[o]C Avoid freeze/thaw cycles.
Hersteller:
Sanyou Biopharmaceuticals
Typ:
Antibody: Biosimilar Antibody
  • Datenblatt des Herstellers:CHA048
Anti-FOLR1 / FRA Reference Antibody (farletuzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-FOLR1 / FRA Reference Antibody (farletuzumab) is 95.5%, determined by SEC-HPLC.
Cyno FRA Alpha HEK293 cells were stained with Anti-FOLR1 / FRA Reference Antibody (farletuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.326 ug/mL.
The endocytosis ratio farletuzumab by Human FrA Alpha HEK 293 increased with the increase of antibody concentration, and the Internalization Rate (%) reached 75% at antibody concentration of 55 ng/mL.